drugset / Trial / NCT05539833
KSH01-TCRT Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
1\) Safety and efficacy of TCR-T cells in subjects with refractory/relapsed solid tumors. 2) The activation and proliferation of TCR-T cells in the subject, and the survival time.
Timeline
- Start
- 2022-08-19
- Primary completion
- 2025-07-31
- Completion
- 2027-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KSH01 | Cell therapy | — | — |